Literature DB >> 2660699

The molecular regulators of macrophage and granulocyte development. Role of MGI-2/IL-6.

L Sachs1, J Lotem, Y Shabo.   

Abstract

The development of a cell culture system for the in vitro cloning and clonal differentiation of normal hematopoietic cells made it possible to identify the proteins that regulate growth and differentiation of different hematopoietic cell lineages and the change in normal controls that produce leukemia. A model system with myeloid cells has identified different myeloid cell colony-inducing proteins, which we called MGI-1 (= CSF, including IL-3). There is another protein that we first described in 1976 and called MGI-2 in 1980 that induces differentiation of myeloid cells to macrophages or granulocytes without inducing the clonal growth of myeloid cells. The four CSF proteins and IL-1 induce the production of MGI-2 in myeloid cells and MGI-2 induces the production of GM-CSF. This shows the participation of MGI-2 in the network of interactions with different myeloid regulatory proteins. Using a monoclonal antibody to MGI-2, amino acid sequencing, and recombinant protein, we have shown in collaboration with the Genetics Institute that the major form of MGI-2 (MGI-2A) is IL-6. This shows that IL-6 is a myeloid cell differentiation inducing protein. The results also suggest new clinical potentials for MGI-2/IL-6.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2660699     DOI: 10.1111/j.1749-6632.1989.tb24035.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  7 in total

1.  Stimulation of thrombopoiesis in mice by human recombinant interleukin 6.

Authors:  R J Hill; M K Warren; J Levin
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

2.  Periostin controls keratinocyte proliferation and differentiation by interacting with the paracrine IL-1α/IL-6 loop.

Authors:  Kazuto Taniguchi; Kazuhiko Arima; Miho Masuoka; Shoichiro Ohta; Hiroshi Shiraishi; Kanako Ontsuka; Shoichi Suzuki; Masako Inamitsu; Ken-Ichi Yamamoto; Olga Simmons; Shuji Toda; Simon J Conway; Yuhei Hamasaki; Kenji Izuhara
Journal:  J Invest Dermatol       Date:  2013-11-25       Impact factor: 8.551

3.  Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis.

Authors:  B Motro; A Itin; L Sachs; E Keshet
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

Review 4.  Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?

Authors:  W L Biffl; E E Moore; F A Moore; V M Peterson
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

Review 5.  Interleukin-6 in clinical medicine.

Authors:  J Bauer; F Herrmann
Journal:  Ann Hematol       Date:  1991-06       Impact factor: 3.673

Review 6.  Inflammatory cytokines in systemic lupus erythematosus.

Authors:  Kim Ohl; Klaus Tenbrock
Journal:  J Biomed Biotechnol       Date:  2011-10-16

7.  Neonatal LPS Administered Before Sensitization Reduced the Number of Inflammatory Monocytes and Abrogated the Development of OVA-Induced Th2 Allergic Airway Inflammation.

Authors:  Liuchuang Gao; Min Wu; Hangyu Liu; Miao He; Han Jiang; Runshi Shang; Qiangqiang Wang; Zhu Song; Yafei Huang; Junyan Han
Journal:  Front Immunol       Date:  2021-09-22       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.